A cell-targeted, payload-delivering DNA nanorobot developed at the Wyss Institute (2013) that can trigger targeted therapeutic responses. This novel technology could potentially seek out cancer cells and cause them to self-destruct
IEC: Use case session 2 – Sensor technology / General purpose technology and dual use concerns - Healthcare / Diversity and liability concerns AI with "Trust"
A cell-targeted, payload-delivering DNA nanorobot developed at the Wyss Institute (2013) that can trigger targeted therapeutic responses. This novel technology could potentially seek out cancer cells and cause them to self-destruct